June 14, 2025 a 06:00 pm

GEHC: Fundamental Ratio Analysis - GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc. has shown promising growth potential due to its diversified approach to medical imaging and diagnostic solutions. The company's strong focus on digital innovations enhances its market position. Despite certain financial challenges, the firm’s forward-looking strategy indicates a potential for long-term value creation.

Fundamental Rating

GE HealthCare Technologies Inc. exhibits a strong fundamental position, highlighted by steady cash flow management and robust return on equity.

Metric Score Visualization
Discounted Cash Flow (DCF) 4
Return on Equity (ROE) 5
Return on Assets (ROA) 5
Debt to Equity 1
Price to Earnings (P/E) 2
Price to Book (P/B) 2

Historical Rating

The historical ratings reflect consistent performance, with robust scores in key financial metrics over different periods.

Date Overall DCF ROE ROA Debt/Equity P/E P/B
2025-06-13 3 4 5 5 1 2 2
2024-06-13 0 4 5 5 1 2 2

Analyst Price Targets

Analysts suggest a stable outlook for GEHC with a median target price indicating moderate growth potential.

High Low Median Consensus
95 73 84 84
Stock Chart

Analyst Sentiment

There is a positive analyst sentiment towards GEHC, with a significant portion of recommendations being 'Buy'.

Rating Count Distribution
Strong Buy 0
Buy 12
Hold 4
Sell 0
Strong Sell 0

Conclusion

GE HealthCare Technologies Inc. presents a compelling investment case due to its solid market position and innovative product portfolio. While there are financial challenges, particularly with debt management, the growth potential in the expanding healthcare technology sector could outweigh these risks. Positive analyst sentiment and favorable price targets suggest room for upward momentum. Overall, the company’s blend of technological innovation and commitment to healthcare solutions sets it apart in the industry.